logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 6
  • 1
    Clark, James John
    Born in January 1973
    Individual (3 offsprings)
    Officer
    2019-07-03 ~ now
    OF - Director → CIF 0
  • 2
    Hirst, John, Dr
    Born in August 1952
    Individual (4 offsprings)
    Officer
    2021-09-21 ~ now
    OF - Director → CIF 0
  • 3
    Little, Stephen
    Born in January 1957
    Individual (3 offsprings)
    Officer
    2021-09-21 ~ now
    OF - Director → CIF 0
  • 4
    Andrews, Ronald
    Born in July 1959
    Individual (1 offspring)
    Officer
    2025-10-31 ~ now
    OF - Director → CIF 0
  • 5
    Thompson, Andrew James, Dr
    Born in June 1973
    Individual (2 offsprings)
    Officer
    2018-01-29 ~ now
    OF - Director → CIF 0
  • 6
    First Floor, 12/14 Mason's Avenue, London, England
    Active Corporate (3 parents, 2 offsprings)
    Equity (Company account)
    1 GBP2024-12-31
    Person with significant control
    2022-02-01 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
Ceased 1
  • Mr Andrew James Thompson
    Born in June 1973
    Individual (2 offsprings)
    Person with significant control
    2018-01-29 ~ 2025-04-03
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

SMI DRUG DISCOVERY LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
132024-01-01 ~ 2024-12-31
122023-01-01 ~ 2023-12-31
Intangible Assets
116,592 GBP2024-12-31
84,515 GBP2023-12-31
Property, Plant & Equipment
25,791 GBP2024-12-31
21,739 GBP2023-12-31
Fixed Assets
142,383 GBP2024-12-31
106,254 GBP2023-12-31
Debtors
Current
407,112 GBP2024-12-31
304,350 GBP2023-12-31
Cash at bank and in hand
668,805 GBP2024-12-31
484,095 GBP2023-12-31
Current Assets
1,075,917 GBP2024-12-31
788,445 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-86,614 GBP2024-12-31
Net Current Assets/Liabilities
989,303 GBP2024-12-31
708,259 GBP2023-12-31
Net Assets/Liabilities
1,131,686 GBP2024-12-31
814,513 GBP2023-12-31
Equity
Called up share capital
8,845 GBP2024-12-31
8,159 GBP2023-12-31
Share premium
4,945,162 GBP2024-12-31
3,129,202 GBP2023-12-31
Retained earnings (accumulated losses)
-3,822,321 GBP2024-12-31
-2,322,848 GBP2023-12-31
Equity
1,131,686 GBP2024-12-31
814,513 GBP2023-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
118,410 GBP2024-12-31
84,999 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
1,818 GBP2024-12-31
484 GBP2023-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
116,592 GBP2024-12-31
84,515 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
Office equipment
14,583 GBP2024-12-31
13,856 GBP2023-12-31
Computers
38,584 GBP2024-12-31
36,845 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
68,055 GBP2024-12-31
50,701 GBP2023-12-31
Plant and equipment
14,501 GBP2024-12-31
Furniture and fittings
387 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Office equipment
4,966 GBP2023-12-31
Computers
23,996 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
28,962 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
767 GBP2024-01-01 ~ 2024-12-31
Office equipment, Owned/Freehold
2,869 GBP2024-01-01 ~ 2024-12-31
Owned/Freehold
13,302 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
767 GBP2024-12-31
Furniture and fittings
61 GBP2024-12-31
Office equipment
7,835 GBP2024-12-31
Computers
33,601 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
42,264 GBP2024-12-31
Property, Plant & Equipment
Plant and equipment
13,734 GBP2024-12-31
Furniture and fittings
326 GBP2024-12-31
Office equipment
6,748 GBP2024-12-31
8,890 GBP2023-12-31
Computers
4,983 GBP2024-12-31
12,849 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
17,311 GBP2024-12-31
51,624 GBP2023-12-31
Other Debtors
Current
360,947 GBP2024-12-31
224,202 GBP2023-12-31
Prepayments/Accrued Income
Current
28,854 GBP2024-12-31
28,524 GBP2023-12-31
Trade Creditors/Trade Payables
Current
15,624 GBP2024-12-31
15,428 GBP2023-12-31
Taxation/Social Security Payable
Current
20,611 GBP2024-12-31
22,024 GBP2023-12-31
Other Creditors
Current
31,309 GBP2024-12-31
30,292 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
19,070 GBP2024-12-31
12,442 GBP2023-12-31
Creditors
Current
86,614 GBP2024-12-31
80,186 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
4,274,973 shares2024-12-31
3,638,820 shares2023-12-31
Par Value of Share
Class 2 ordinary share
0.0012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
3,960,000 shares2024-12-31
3,960,000 shares2023-12-31
Par Value of Share
Class 3 ordinary share
0.0012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
450,000 shares2024-12-31
400,000 shares2023-12-31
Par Value of Share
Class 4 ordinary share
0.0012024-01-01 ~ 2024-12-31
  • SMI DRUG DISCOVERY LIMITED
    Info
    Registered number 11175710
    23 Longmeadow, Lode, Cambridge CB25 9HA
    PRIVATE LIMITED COMPANY incorporated on 2018-01-29 (8 years). The company status is Active.
    The last date of confirmation statement was made at 2025-01-06
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.